EPCAM and carcinoma: The expression of the selected subset of immunotherapy target genes was further evaluated by real-time PCR in sorted stromal (EPCAM−) and carcinoma (EPCAM+) cell populations from the P2726.Ov PHT and in EPCAM+ human cells from the first and ninth generation CXs of this tumor (Figure 5B).